Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.
| Revenue (TTM) | 574,240 |
| Gross Profit (TTM) | 574,240 |
| EBITDA | $-6.97M |
| Operating Margin | 0.00% |
| Return on Equity | -142.90% |
| Return on Assets | -66.60% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $3.11 |
| Price-to-Book | 0.93 |
| Price-to-Sales (TTM) | 2.37 |
| EV/Revenue | 18.8 |
| EV/EBITDA | 51.98 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4278.00% |
| Shares Outstanding | $2.37M |
| Float | $1.48M |
| % Insiders | 5.95% |
| % Institutions | 6.46% |
Volatility is currently contracting